To understand the clinicopathological significance of RUNX1 in NSCLC, we analyzed the methylation status of RUNX1 in different types of samples from a total of 118 NSCLC patients and 60 healthy individuals. The gene discussed is RUNX1; the disease is non-small cell lung carcinoma.